Willoughby E W, Dupont B, Good R A
Ann Neurol. 1979 Apr;5(4):391-3. doi: 10.1002/ana.410050415.
Production of the lymphokine LIF (leukocyte migration inhibitory factor) by normal lymphocytes on stimulation with mitogens in inhibited by E type prostaglandins (PGE). It has been reported that the leukocytes of patients with multiple sclerosis (MS) are resistant to this inhibitory effect. We have studied 10 MS patients using an indirect technique for measuring LIF activity. This allows separation of the effects of PGE on lymphocyte LIF production from the effects on the action of LIF on the target granulocytes. There was no difference between normal subjects and MS patients in the effects of prostaglandins E1 and E2 in concentrations of 2.5 and 0.25 microgram per milliliter, on LIF production, or on granulocyte response to LIF. These results do not support the hypothesis that the chronic inflammatory process in MS is the result of resistance to the normal inhibitory effects of PGE on the cellular immune response.
正常淋巴细胞在有丝分裂原刺激下产生淋巴因子LIF(白细胞迁移抑制因子)的过程会受到E型前列腺素(PGE)的抑制。据报道,多发性硬化症(MS)患者的白细胞对这种抑制作用具有抗性。我们使用一种间接技术来测量LIF活性,对10名MS患者进行了研究。这使得能够将PGE对淋巴细胞LIF产生的影响与对LIF作用于靶粒细胞的影响区分开来。每毫升浓度为2.5微克和0.25微克的前列腺素E1和E2,在对LIF产生或对粒细胞对LIF的反应方面,正常受试者和MS患者之间没有差异。这些结果不支持MS中的慢性炎症过程是对PGE对细胞免疫反应的正常抑制作用产生抗性的结果这一假设。